Generate a tailored SOP for Dr. Cecilia Williams. Improve your application with a focused, well-structured draft.
Cecilia Williams is a professor at the KTH Royal Institute of Technology, focusing on cellular clinical proteomics and the molecular mechanisms of cancer. Her research investigates how estrogen signaling influences the risk of breast cancer while potentially offering protective effects against colon cancer. Through her work, Williams aims to elucidate the intricate molecular pathways involved in cancer development, emphasizing the role of sex differences and dietary factors. She employs large-scale omic techniques and mechanistic experiments to explore how the tumor microenvironment interacts with immune responses and microbiota. Her research is supported by numerous grants and aims to provide insights into preventive strategies and biomarkers for clinical application. Williams has published extensively on topics including estrogen receptors, cancer therapeutics, and metabolic influences on cancer biology.
KTH Royal Institute of Technology • Stockholm, Sweden
Leading research in cellular clinical proteomics and cancer mechanisms.
Master's programs are organized under Schools; departments listed are units within these schools (e.g., EECS, ABE, CBH, ITM, SCI).